What do we still need to know?
The US Food and Drug Administration (FDA) entry for injectable GHK-Cu was checked on September 30, 2026.
The FDA warns that the body may treat injected GHK-Cu as a foreign substance and react against it.
Clumps of the peptide or unwanted substances in the product are part of its concern.
The warning does not name specific symptoms or describe a confirmed reaction in a patient.
It says there is little information from people to judge injection safety. [a]
Is there an official list of people who need to avoid it?
As of September 30, 2026, GHK-Cu had no official FDA-reviewed instructions about pregnancy or effects with other medicines.
There was also no FDA-reviewed list of people who need to avoid it.
These gaps do not prove that it is harmless. [b]
Which gaps do I want to discuss?
Mark topics to bring up, then add the question that is on your mind.
In Wilson disease, copper builds up in the body.
The September 30, 2026 research check found no GHK-Cu study in people with Wilson disease. [e]
When is urgent help needed?
A severe allergic reaction may cause the tongue or face to swell, or make it hard to breathe.
Severe signs of an allergic reaction need help right away: dial 911 or go to an emergency room. [c]
How can a medicine problem be reported?
To report a medicine problem, patients can use MedWatch, the FDA’s reporting service. [d]